Intrinsic value of The Hartford Healthcare Fund Class A (HGHAX)
Live fair value data for The Hartford Healthcare Fund Class A (HGHAX) is currently unavailable. Please check again shortly.
Current Price: $348.00
Valuation: Overvalued
Confidence: 5.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is The Hartford Healthcare Fund Class A (HGHAX) undervalued or overvalued?
Based on the current model output, The Hartford Healthcare Fund Class A appears to be overvalued with a downside of 19.00%.
Fair value vs market price — The Hartford Healthcare Fund Class A (HGHAX)
Unlock premium access to view the live fair value comparison against current market price for HGHAX.
Frequently Asked Questions - HGHAX
How is HGHAX intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for HGHAX.
Is HGHAX undervalued or overvalued right now?
HGHAX is currently shown as overvalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for HGHAX: open their intrinsic value pages.
- EEMAXColumbia Emerging Markets Fund Class A
- HHyatt Hotels Corporation
- FAMEXFAM Dividend Focus Fund Investor
- CIMDXCLARKSTON FOUNDERS FUND, Institutional Class
- VLAIXValue Line Asset Allocation Fund Institutional Class
- GGTThe Gabelli Multimedia Trust Inc.
- GGenpact Limited
- VLAAXValue Line Asset Allocation Fund Investor Class